{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T01:36:28Z","timestamp":1792460188340,"version":"4.5.0"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,10,21]],"date-time":"2024-10-21T00:00:00Z","timestamp":1729468800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,10,21]],"date-time":"2024-10-21T00:00:00Z","timestamp":1729468800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Hefei Applied Medicine Program","award":["Hwk2023zd021"],"award-info":[{"award-number":["Hwk2023zd021"]}]},{"name":"the School Research Fund of Anhui Medical University","award":["2023xkj110"],"award-info":[{"award-number":["2023xkj110"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Nat Med"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1007\/s11418-024-01849-4","type":"journal-article","created":{"date-parts":[[2024,10,21]],"date-time":"2024-10-21T17:02:52Z","timestamp":1729530172000},"page":"82-94","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Angelic acid triggers ferroptosis in colorectal cancer cells via targeting and impairing NRF2 protein stability"],"prefix":"10.1007","volume":"79","author":[{"given":"Yongyi","family":"Cao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yueyang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sihan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lizhe","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ting","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,10,21]]},"reference":[{"issue":"1","key":"1849_CR1","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3322\/caac.21708","volume":"72","author":"RL Siegel","year":"2022","unstructured":"Siegel RL, Miller KD, Fuchs HE, Jemal A (2022) Cancer statistics 2022. CA Cancer J Clin 72(1):7\u201333. https:\/\/doi.org\/10.3322\/caac.21708","journal-title":"CA Cancer J Clin"},{"issue":"9","key":"1849_CR2","doi-asserted-by":"publisher","first-page":"3142","DOI":"10.1111\/cas.14532","volume":"111","author":"S Blondy","year":"2020","unstructured":"Blondy S, David V, Verdier M, Mathonnet M, Perraud A, Christou N (2020) 5-Fluorouracil resistance mechanisms in colorectal cancer: from classical pathways to promising processes. Cancer Sci 111(9):3142\u20133154. https:\/\/doi.org\/10.1111\/cas.14532","journal-title":"Cancer Sci"},{"issue":"1","key":"1849_CR3","doi-asserted-by":"publisher","first-page":"1078","DOI":"10.1038\/s41467-019-08902-x","volume":"10","author":"J Ou","year":"2019","unstructured":"Ou J, Peng Y, Yang W, Zhang Y, Hao J, Li F, Chen Y, Zhao Y, Xie X, Wu S, Zha L, Luo X, Xie GF, Wang LT, Sun W, Zhou Q, Li JJ, Liang HJ (2019) ABHD5 blunts the sensitivity of colorectal cancer to fluorouracil via promoting autophagic uracil yield. Nat Commun 10(1):1078. https:\/\/doi.org\/10.1038\/s41467-019-08902-x","journal-title":"Nat Commun"},{"issue":"14","key":"1849_CR4","doi-asserted-by":"publisher","first-page":"2401","DOI":"10.1016\/j.cell.2022.06.003","volume":"185","author":"BR Stockwell","year":"2022","unstructured":"Stockwell BR (2022) Ferroptosis turns 10: Emerging mechanisms, physiological functions, and therapeutic applications. Cell 185(14):2401\u20132421. https:\/\/doi.org\/10.1016\/j.cell.2022.06.003","journal-title":"Cell"},{"issue":"7","key":"1849_CR5","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1038\/s41568-022-00459-0","volume":"22","author":"G Lei","year":"2022","unstructured":"Lei G, Zhuang L, Gan B (2022) Targeting ferroptosis as a vulnerability in cancer. Nat Rev Cancer 22(7):381\u2013396. https:\/\/doi.org\/10.1038\/s41568-022-00459-0","journal-title":"Nat Rev Cancer"},{"key":"1849_CR6","doi-asserted-by":"publisher","first-page":"9","DOI":"10.3390\/antiox12091739","volume":"12","author":"R Yan","year":"2023","unstructured":"Yan R, Lin B, Jin W, Tang L, Hu S, Cai R (2023) NRF2, a superstar of ferroptosis. Antioxidants 12:9. https:\/\/doi.org\/10.3390\/antiox12091739","journal-title":"Antioxidants"},{"issue":"10","key":"1849_CR7","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1038\/nchem.2778","volume":"9","author":"TT Mai","year":"2017","unstructured":"Mai TT, Hama\u00ef A, Hienzsch A (2017) Salinomycin kills cancer stem cells by sequestering iron in lysosomes. Nat Chem 9(10):1025\u20131033. https:\/\/doi.org\/10.1038\/nchem.2778","journal-title":"Nat Chem"},{"key":"1849_CR8","doi-asserted-by":"publisher","first-page":"1399677","DOI":"10.3389\/fphar.2024","volume":"15","author":"P Pandey","year":"2024","unstructured":"Pandey P, Elsori D, Kumar R, Lakhanpal S, Rautela I, Alqahtani TM, Ahmad F, Iqbal D, Khan F (2024) Ferroptosis targeting natural compounds as a promising approach for developing potent liver cancer agents. Front Pharmacol 15:1399677. https:\/\/doi.org\/10.3389\/fphar.2024","journal-title":"Front Pharmacol"},{"key":"1849_CR9","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2022.102426","author":"H Chen","year":"2022","unstructured":"Chen H, Qi Q, Wu N, Wang Y, Feng Q, Jin R, Jiang L (2022) Aspirin promotes RSL3-induced ferroptosis by suppressing mTOR\/SREBP-1\/SCD1-mediated lipogenesis in PIK3CA-mutant colorectal cancer. Redox biol. https:\/\/doi.org\/10.1016\/j.redox.2022.102426","journal-title":"Redox biol"},{"key":"1849_CR10","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2024.116345","author":"R Fu","year":"2024","unstructured":"Fu R, You Y, Wang Y, Wang J, Lu Y, Gao R, Pang M, Yang P (2024) Wang H (2024) Sanggenol L induces ferroptosis in non-small cell lung cancer cells via regulating the miR-26a-1-3p\/MDM2\/p53 signaling pathway. Biochem Pharmacol. https:\/\/doi.org\/10.1016\/j.bcp.2024.116345","journal-title":"Biochem Pharmacol"},{"key":"1849_CR11","doi-asserted-by":"publisher","DOI":"10.1016\/j.tranon.2022.101345","author":"M Zhong","year":"2022","unstructured":"Zhong M, Li X, Zhao F, Huang Y, Long Y, Chen K, Tian X, Liu M, Ma X (2022) Natural compound library screening identifies Sanguinarine chloride for the treatment of SCLC by upregulating CDKN1A. Transl Oncol. https:\/\/doi.org\/10.1016\/j.tranon.2022.101345","journal-title":"Transl Oncol"},{"issue":"9","key":"1849_CR12","doi-asserted-by":"publisher","first-page":"2100","DOI":"10.3390\/molecules29092100","volume":"29","author":"LL Chen","year":"2024","unstructured":"Chen LL, Fan B, Wang FZ, Song Y, Wang XZ, Meng Y, Chen YM, Xia Q, Sun J (2024) Research progress in pharmacological effects and mechanisms of angelica sinensis against cardiovascular and cerebrovascular diseases. Molecules 29(9):2100. https:\/\/doi.org\/10.3390\/molecules29092100","journal-title":"Molecules"},{"key":"1849_CR13","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2024.116429","author":"XD Zhi","year":"2024","unstructured":"Zhi XD, Ren CZ, Li QR, Xi HQ, Li D, Chen QL, Lv XF, Gao X, Wu X, Wang CL, Jiang B, Mao ZN, Jiang H, Liu K, Zhao XK, Li YD (2024) Therapeutic potential of Angelica sinensis in addressing organ fibrosis: a comprehensive review. Biomed Pharmacother. https:\/\/doi.org\/10.1016\/j.biopha.2024.116429","journal-title":"Biomed Pharmacother"},{"issue":"1","key":"1849_CR14","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1080\/10717544.2021.2021324","volume":"29","author":"X Liu","year":"2022","unstructured":"Liu X, Wu Z, Guo C, Guo H, Su Y, Chen Q, Sun C, Liu Q (2022) Chen D (2022) Hypoxia responsive nano-drug delivery system based on angelica polysaccharide for liver cancer therapy. Drug Deliv 29(1):138\u2013148. https:\/\/doi.org\/10.1080\/10717544.2021.2021324","journal-title":"Drug Deliv"},{"issue":"1","key":"1849_CR15","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/s41702-017-0013-4","volume":"2","author":"J-E Ku","year":"2018","unstructured":"Ku J-E (2018) Photodamage attenuation effect by angelic acid in UVA irradiation-induced damages in normal human dermal fibroblast. Biomed Dermatol 2(1):8. https:\/\/doi.org\/10.1186\/s41702-017-0013-4","journal-title":"Biomed Dermatol"},{"issue":"W1","key":"1849_CR16","doi-asserted-by":"publisher","first-page":"W739","DOI":"10.1093\/nar\/gkac382","volume":"50","author":"A Ianevski","year":"2022","unstructured":"Ianevski A, Giri AK, Aittokallio T (2022) SynergyFinder 3.0: an interactive analysis and consensus interpretation of multi-drug synergies across multiple samples. Nucleic Acids Res 50(W1):W739-w743. https:\/\/doi.org\/10.1093\/nar\/gkac382","journal-title":"Nucleic Acids Res"},{"key":"1849_CR17","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202307899","author":"XQ Guan","year":"2024","unstructured":"Guan XQ, Wang YC, Yu WK, Wei Y, Lu Y, Dai EY, Dong XW, Zhao B, Hu C, Yuan L, Miao K, Chen BN, Cheng XD, Zhang WD, Qin JJ (2024) Blocking ubiquitin-specific protease 7 induces ferroptosis in gastric cancer via targeting stearoyl-CoA desaturase. ADv Sci. https:\/\/doi.org\/10.1002\/advs.202307899","journal-title":"ADv Sci"},{"issue":"8","key":"1849_CR18","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1016\/10.1038\/s41419-019-1825-5","volume":"10","author":"R Fu","year":"2019","unstructured":"Fu R, Yang P, Li Z, Liu W, Amin S, Li Z (2019) Avenanthramide A triggers potent ROS-mediated anti-tumor effects in colorectal cancer by directly targeting DDX3. Cell Death Dis 10(8):593. https:\/\/doi.org\/10.1016\/10.1038\/s41419-019-1825-5","journal-title":"Cell Death Dis"},{"key":"1849_CR19","doi-asserted-by":"publisher","DOI":"10.1016\/j.apsb.2024.07.018","author":"R Fu","year":"2024","unstructured":"Fu R, Dou ZF, Li N, Fan XY, Sajid A, Zhang JQ, Wang YQ, Li ZW, Li ZY, Yang P (2024) Avenanthramide A potentiates Bim-mediated antineoplastic properties of 5-fluorouracil via targeting KDM4C\/MIR17HG\/GSK-3\u03b2 negative feedback loop in colorectal cancer. Acta Pharm Sin B. https:\/\/doi.org\/10.1016\/j.apsb.2024.07.018","journal-title":"Acta Pharm Sin B"},{"issue":"3","key":"1849_CR20","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1016\/j.chembiol.2023.02.003","volume":"30","author":"C Lv","year":"2023","unstructured":"Lv C, Huang Y, Wang Q, Wang CJ, Hu HM, Zhang HW, Lu D, Jiang HH, Shen R, Zhang WD, Liu SH (2023) Ainsliadimer A induces ROS-mediated apoptosis in colorectal cancer cells via directly targeting peroxiredoxin 1 and 2. Cell Chem Biol 30(3):295-307.e295. https:\/\/doi.org\/10.1016\/j.chembiol.2023.02.003","journal-title":"Cell Chem Biol"},{"issue":"1","key":"1849_CR21","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1038\/s41392-021-00605-4","volume":"6","author":"Y Zhao","year":"2021","unstructured":"Zhao Y, Shim N, Cui YH, Kang JH, Yoo KC, Kim S, Yi JM, Kim MJ, Yoon JH, Lee SJ (2021) FBXO15 plays a critical suppressive functional role in regulation of breast cancer progression. Signal Transduct Target Ther 6(1):211. https:\/\/doi.org\/10.1038\/s41392-021-00605-4","journal-title":"Signal Transduct Target Ther"},{"issue":"1","key":"1849_CR22","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1186\/s13104-021-05445-7","volume":"14","author":"P M\u00e4kel\u00e4","year":"2021","unstructured":"M\u00e4kel\u00e4 P, Zhang SM, Rudd SG (2021) Drug synergy scoring using minimal dose response matrices. BMC Res Notes 14(1):27. https:\/\/doi.org\/10.1186\/s13104-021-05445-7","journal-title":"BMC Res Notes"},{"key":"1849_CR23","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1007\/978-1-4939-7493-1_17","volume":"1711","author":"L He","year":"2018","unstructured":"He L, Kulesskiy E, Saarela J, Turunen L, Wennerberg K, Aittokallio T, Tang J (2018) Methods for high-throughput drug combination screening and synergy scoring. Methods Mol Biol 1711:351\u2013398. https:\/\/doi.org\/10.1007\/978-1-4939-7493-1_17","journal-title":"Methods Mol Biol"},{"issue":"1","key":"1849_CR24","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.1038\/s41467-023-36630-w","volume":"14","author":"PS Upadhyayula","year":"2023","unstructured":"Upadhyayula PS, Higgins DM, Mela A, Banu M, Dovas A, Zandkarimi F, Patel P, Mahajan A, Humala N, Nguyen TT, Chaudhary KR, Liao L, Argenziano M, Sudhakar T, Sperring CP, Shapiro BL, Ahmed ER, Kinnslow C, Ye LF, Siegelin MD, Cheng S, Soni R, Bruce JN, Stockwell BR, Canoll P (2023) Dietary restriction of cysteine and methionine sensitizes gliomas to ferroptosis and induces alterations in energetic metabolism. Nat Commun 14(1):1187. https:\/\/doi.org\/10.1038\/s41467-023-36630-w","journal-title":"Nat Commun"},{"issue":"1","key":"1849_CR25","doi-asserted-by":"publisher","first-page":"4758","DOI":"10.1038\/s41467-023-40518-0","volume":"14","author":"Y Xue","year":"2023","unstructured":"Xue Y, Lu FJ, Chang ZZ, Li J, Gao Y, Zhou J, Luo Y, Lai YF, Cao SY, Li XX, Zhou YH, Li Y, Tan Z, Cheng X, Li X, Chen J, Wang WM (2023) Intermittent dietary methionine deprivation facilitates tumoral ferroptosis and synergizes with checkpoint blockade. Nat Commun 14(1):4758. https:\/\/doi.org\/10.1038\/s41467-023-40518-0","journal-title":"Nat Commun"},{"key":"1849_CR26","doi-asserted-by":"publisher","DOI":"10.1038\/s41556-024-01425-8","author":"T Nakamura","year":"2024","unstructured":"Nakamura T, Conrad M (2024) Exploiting ferroptosis vulnerabilities in cancer. Nat Cell Biol. https:\/\/doi.org\/10.1038\/s41556-024-01425-8","journal-title":"Nat Cell Biol"},{"issue":"4","key":"1849_CR27","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1038\/s43018-023-00715-8","volume":"5","author":"H Zheng","year":"2024","unstructured":"Zheng H, Liu JM, Cheng Q, Zhang QP, Zhang YY, Jiang JLY, Huang Y, Li WL, Zhao YP, Chen G, Yu F, Liu L, Li YJ, Liao XD, Xu L, Xiao Y, Zheng ZB, Li M, Wang HY, Hu G, Du L, Chen Q (2024) Targeted activation of ferroptosis in colorectal cancer via LGR4 targeting overcomes acquired drug resistance. Nat Cancer 5(4):572\u2013589. https:\/\/doi.org\/10.1038\/s43018-023-00715-8","journal-title":"Nat Cancer"},{"issue":"9","key":"1849_CR28","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1007\/s00018-023-04907-4","volume":"80","author":"YQ Ren","year":"2023","unstructured":"Ren YQ, Mao XR, Xu H, Dang Q, Weng SY, Zhang YY, Chen S, Liu ST, Ba YH, Zhou ZK, Han XW, Liu ZQ, Zhang GJ (2023) Ferroptosis and EMT: key targets for combating cancer progression and therapy resistance. Cell Mol Life Sci 80(9):263. https:\/\/doi.org\/10.1007\/s00018-023-04907-4","journal-title":"Cell Mol Life Sci"},{"issue":"6","key":"1849_CR29","doi-asserted-by":"publisher","first-page":"1409","DOI":"10.1111\/bph.14816","volume":"177","author":"SR Lin","year":"2020","unstructured":"Lin SR, Chang CH, Hsu CF, Tsai MJ, Cheng H, Leong MK, Sung PJ, Chen JC, Weng CF (2020) Natural compounds as potential adjuvants to cancer therapy: preclinical evidence. Br J Pharmacol 177(6):1409\u20131423. https:\/\/doi.org\/10.1111\/bph.14816","journal-title":"Br J Pharmacol"},{"issue":"1","key":"1849_CR30","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.1038\/s41467-019-09186-x","volume":"10","author":"FX Cheng","year":"2019","unstructured":"Cheng FX, Kov\u00e1cs IA, Barab\u00e1si AL (2019) Network-based prediction of drug combinations. Nat Commun 10(1):1197. https:\/\/doi.org\/10.1038\/s41467-019-09186-x","journal-title":"Nat Commun"},{"issue":"7","key":"1849_CR31","doi-asserted-by":"publisher","first-page":"1688","DOI":"10.1111\/febs.16382","volume":"290","author":"H Nishizawa","year":"2023","unstructured":"Nishizawa H, Yamanaka M, Igarashi K (2023) Ferroptosis: regulation by competition between NRF2 and BACH1 and propagation of the death signal. FEBS J 290(7):1688\u20131704. https:\/\/doi.org\/10.1111\/febs.16382","journal-title":"FEBS J"},{"issue":"1","key":"1849_CR32","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.ccell.2018.03.022","volume":"34","author":"DLVM Rojo","year":"2018","unstructured":"Rojo DLVM, Chapman E, Zhang DD (2018) NRF2 and the hallmarks of cancer. Cancer Cell 34(1):21\u201343. https:\/\/doi.org\/10.1016\/j.ccell.2018.03.022","journal-title":"Cancer Cell"},{"key":"1849_CR33","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2024.103287","author":"Q Zhang","year":"2024","unstructured":"Zhang Q, Chen ZH, Li JL, Huang KP, Ding ZH, Chen B, Ren TX, Xu P, Wang GL, Zhang HJ, Zhang XD, Zhang JX, Wang H (2024) The deubiquitinase OTUD1 stabilizes NRF2 to alleviate hepatic ischemia\/reperfusion injury. Redox Biol. https:\/\/doi.org\/10.1016\/j.redox.2024.103287","journal-title":"Redox Biol"},{"issue":"9","key":"1849_CR34","doi-asserted-by":"publisher","first-page":"1706","DOI":"10.1038\/s41388-021-01660-5","volume":"40","author":"CJ Meng","year":"2021","unstructured":"Meng CJ, Zhan J, Chen DL, Shao GZ, Zhang HQ, Gu W, Luo JY (2021) The deubiquitinase USP11 regulates cell proliferation and ferroptotic cell death via stabilization of NRF2 USP11 deubiquitinates and stabilizes NRF2. Oncogene 40(9):1706\u20131720. https:\/\/doi.org\/10.1038\/s41388-021-01660-5","journal-title":"Oncogene"},{"issue":"11","key":"1849_CR35","doi-asserted-by":"publisher","first-page":"2300","DOI":"10.1038\/s41418-019-0303-z","volume":"26","author":"Q Zhang","year":"2019","unstructured":"Zhang Q, Zhang ZY, Du H, Li SZ, Tu RF, Jia YF, Zheng Z, Song XM, Du RL, Zhang XD (2019) DUB3 deubiquitinates and stabilizes NRF2 in chemotherapy resistance of colorectal cancer. Cell Death Differ 26(11):2300\u20132313. https:\/\/doi.org\/10.1038\/s41418-019-0303-z","journal-title":"Cell Death Differ"},{"issue":"7784","key":"1849_CR36","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1038\/s41586-019-1707-0","volume":"575","author":"S Doll","year":"2019","unstructured":"Doll S, Freitas FP, Shah R, Aldrovandi M, da Silva MC, Ingold I, Goya Grocin A, Xavier da Silva TN, Panzilius E, Scheel CH, Mour\u00e3o A, Buday K, Sato M, Wanninger J, Vignane T, Mohana V, Rehberg M, Flatley A, Schepers A, Kurz A, White D, Sauer M, Sattler M, Tate EW, Schmitz W, Schulze A, Donnell VO, Proneth B, Popowicz GM, Pratt DA, Angeli JPF, Conrad (2019) FSP1 is a glutathione-independent ferroptosis suppressor. Nature 575(7784):693\u2013698. https:\/\/doi.org\/10.1038\/s41586-019-1707-0","journal-title":"Nature"},{"issue":"1","key":"1849_CR37","doi-asserted-by":"publisher","first-page":"2206","DOI":"10.1038\/s41467-022-29905-1","volume":"13","author":"P Koppula","year":"2022","unstructured":"Koppula P, Lei G, Zhang YL, Yan YL, Mao C, Kondiparthi L, Shi JJ, Liu XG, Horbath A, Das M, Li W, Poyurovsky MV, Olszewski K, Gan BY (2022) A targetable CoQ-FSP1 axis drives ferroptosis- and radiation-resistance in KEAP1 inactive lung cancers. Nat Commun 13(1):2206. https:\/\/doi.org\/10.1038\/s41467-022-29905-1","journal-title":"Nat Commun"}],"container-title":["Journal of Natural Medicines"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11418-024-01849-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11418-024-01849-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11418-024-01849-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,15]],"date-time":"2025-01-15T19:05:05Z","timestamp":1736967905000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11418-024-01849-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,21]]},"references-count":37,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,1]]}},"alternative-id":["1849"],"URL":"https:\/\/doi.org\/10.1007\/s11418-024-01849-4","relation":{},"ISSN":["1340-3443","1861-0293"],"issn-type":[{"value":"1340-3443","type":"print"},{"value":"1861-0293","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10,21]]},"assertion":[{"value":"17 August 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 September 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 October 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}